Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.
2.

Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.

Lorin C, Vanloubbeeck Y, Baudart S, Ska M, Bayat B, Brauers G, Clarinval G, Donner MN, Marchand M, Koutsoukos M, Mettens P, Cohen J, Voss G.

PLoS One. 2015 Apr 9;10(4):e0122835. doi: 10.1371/journal.pone.0122835. eCollection 2015.

3.

Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.

Thacher EG, Cavassini M, Audran R, Thierry AC, Bollaerts A, Cohen J, Demoitié MA, Ejigu D, Mettens P, Moris P, Ofori-Anyinam O, Spertini F.

AIDS. 2014 Jul 31;28(12):1769-81. doi: 10.1097/QAD.0000000000000343.

PMID:
24911353
4.

A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.

Montoya J, Solon JA, Cunanan SR, Acosta L, Bollaerts A, Moris P, Janssens M, Jongert E, Demoitié MA, Mettens P, Gatchalian S, Vinals C, Cohen J, Ofori-Anyinam O.

J Clin Immunol. 2013 Nov;33(8):1360-75. doi: 10.1007/s10875-013-9949-3. Epub 2013 Oct 20.

5.

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.

Day CL, Tameris M, Mansoor N, van Rooyen M, de Kock M, Geldenhuys H, Erasmus M, Makhethe L, Hughes EJ, Gelderbloem S, Bollaerts A, Bourguignon P, Cohen J, Demoitié MA, Mettens P, Moris P, Sadoff JC, Hawkridge A, Hussey GD, Mahomed H, Ofori-Anyinam O, Hanekom WA.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502. doi: 10.1164/rccm.201208-1385OC.

6.

The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.

Spertini F, Audran R, Lurati F, Ofori-Anyinam O, Zysset F, Vandepapelière P, Moris P, Demoitié MA, Mettens P, Vinals C, Vastiau I, Jongert E, Cohen J, Ballou WR.

Tuberculosis (Edinb). 2013 Mar;93(2):179-88. doi: 10.1016/j.tube.2012.10.011. Epub 2012 Dec 5.

PMID:
23219236
7.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Lorin C, Segal L, Mols J, Morelle D, Bourguignon P, Rovira O, Mettens P, Silvano J, Dumey N, Le Goff F, Koutsoukos M, Voss G, Tangy F.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1211-25. doi: 10.1007/s00210-012-0793-4. Epub 2012 Sep 16.

8.

Improved CD4⁺ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial.

Leroux-Roels I, Forgus S, De Boever F, Clement F, Demoitié MA, Mettens P, Moris P, Ledent E, Leroux-Roels G, Ofori-Anyinam O; M72 Study Group.

Vaccine. 2013 Apr 19;31(17):2196-206. doi: 10.1016/j.vaccine.2012.05.035. Epub 2012 May 27.

PMID:
22643213
9.

Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Coler RN, Bhatia A, Maisonneuve JF, Probst P, Barth B, Ovendale P, Fang H, Alderson M, Lobet Y, Cohen J, Mettens P, Reed SG.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):258-70. doi: 10.1111/j.1574-695X.2008.00527.x.

10.

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.

Reed SG, Coler RN, Dalemans W, Tan EV, DeLa Cruz EC, Basaraba RJ, Orme IM, Skeiky YA, Alderson MR, Cowgill KD, Prieels JP, Abalos RM, Dubois MC, Cohen J, Mettens P, Lobet Y.

Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2301-6. doi: 10.1073/pnas.0712077106. Epub 2009 Feb 2. Erratum in: Proc Natl Acad Sci U S A.2009 May 5;106(18):7678. Dalemans, Wilifred [corrected to Dalemans, Wilfried].

11.

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.

Mettens P, Dubois PM, Demoitié MA, Bayat B, Donner MN, Bourguignon P, Stewart VA, Heppner DG Jr, Garçon N, Cohen J.

Vaccine. 2008 Feb 20;26(8):1072-82. doi: 10.1016/j.vaccine.2007.12.018. Epub 2008 Jan 7.

PMID:
18258343
12.

Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.

Pichyangkul S, Kum-Arb U, Yongvanitchit K, Limsalakpetch A, Gettayacamin M, Lanar DE, Ware LA, Stewart VA, Heppner DG, Mettens P, Cohen JD, Ballou WR, Fukuda MM.

Infect Immun. 2008 Jan;76(1):229-38. Epub 2007 Oct 22.

13.

Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.

Oliver JL, Pashmi G, Barnett P, Mettens P, Biemans R, Monteyne P, Palmantier R, Gallagher T, Ramaya S, Wonnacott S.

Vaccine. 2007 Oct 16;25(42):7354-62. Epub 2007 Aug 30.

PMID:
17870213
14.

Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.

Stewart VA, McGrath SM, Dubois PM, Pau MG, Mettens P, Shott J, Cobb M, Burge JR, Larson D, Ware LA, Demoitie MA, Weverling GJ, Bayat B, Custers JH, Dubois MC, Cohen J, Goudsmit J, Heppner DG Jr.

Infect Immun. 2007 May;75(5):2283-90. Epub 2007 Feb 16.

15.

Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.

Brando C, Ware LA, Freyberger H, Kathcart A, Barbosa A, Cayphas S, Demoitie MA, Mettens P, Heppner DG, Lanar DE.

Infect Immun. 2007 Feb;75(2):838-45. Epub 2006 Nov 13.

16.

Life-style vaccines.

Mettens P, Monteyne P.

Br Med Bull. 2002;62:175-86. Review.

PMID:
12176859
17.

The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance.

Lespagnard L, Mettens P, De Smedt T, Bazin H, Urbain J, Leo O, Moser M.

Int Immunol. 1998 Mar;10(3):295-304.

PMID:
9576617
18.

Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity.

Lespagnard L, Mettens P, Verheyden AM, Tasiaux N, Thielemans K, van Meirvenne S, Geldhof A, De Baetselier P, Urbain J, Leo O, Moser M.

Int J Cancer. 1998 Apr 13;76(2):250-8.

19.

Role of B7 costimulation in the induction of T and B cell responses by dendritic cells in vivo.

Lespagnard L, Mettens P, Urbain J, Moser M.

Adv Exp Med Biol. 1997;417:529-33. No abstract available.

PMID:
9286415
20.

Effect of muscimol microinjections into the prepositus hypoglossi and the medial vestibular nuclei on cat eye movements.

Mettens P, Godaux E, Cheron G, Galiana HL.

J Neurophysiol. 1994 Aug;72(2):785-802.

PMID:
7983536
21.

Role of the vestibular commissure in gaze-holding in the cat: a pharmacological evaluation.

Mettens P, Cheron G, Godaux E.

Neuroreport. 1994 Jul 21;5(12):1421-4.

PMID:
7948829
22.

NMDA receptors are involved in temporal integration in the oculomotor system of the cat.

Mettens P, Cheron G, Godaux E.

Neuroreport. 1994 Jun 27;5(11):1333-6.

PMID:
7919192
23.
24.
25.

Superovulation and embryo culture in vitro following treatment with ultra-pure follicle-stimulating hormone in cats.

Verstegen JP, Onclin K, Silva LD, Donnay I, Mettens P, Ectors F.

J Reprod Fertil Suppl. 1993;47:209-18.

PMID:
8229928
26.

[Long-latency auditory evoked responses in Parkinson disease and in parkinsonism induced by neuroleptics].

Jacquy J, Mettens P, Blum S, Jacqmotte N, Vanderheyden JE.

Acta Neurol Belg. 1993;93(3):119-29. French.

PMID:
8102219
27.

Gaze holding defect induced by injections of ketamine in the cat brainstem.

Cheron G, Mettens P, Godaux E.

Neuroreport. 1992 Jan;3(1):97-100.

PMID:
1611041
28.

Ketamine induces failure of the oculomotor neural integrator in the cat.

Godaux E, Cheron G, Mettens P.

Neurosci Lett. 1990 Aug 14;116(1-2):162-7.

PMID:
2259445
29.

Effects of ketamine on ocular movements of the cat.

Mettens P, Godaux E, Cheron G.

J Vestib Res. 1990-1991;1(4):325-38.

PMID:
1670165

Supplemental Content

Loading ...
Support Center